Scynexis (SCYX) Other Non-Current Assets (2013 - 2026)
Scynexis (SCYX) reported Other Non-Current Assets of $109000.0 for Q1 2026, down 73.86% on a YoY basis from $417000.0 in Q1 2025, and down 79.55% quarter-over-quarter from $533000.0 in Q4 2025.
Scynexis (SCYX) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Scynexis has reported Other Non-Current Assets for 14 years, with the latest figure at $109000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 73.86% year-over-year to $109000.0; the trailing twelve-month figure through Mar 2026 stood at $109000.0 (down 73.86% YoY), and the FY2025 full-year result was $533000.0, up 27.82% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $109000.0, down from $533000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $6.1 million in Q2 2022, with the low at $73000.0 in Q2 2023.
- Historically, Other Non-Current Assets has averaged $876000.0 across 5 years, with a median of $163000.0 in 2022.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 330.43% — and 2023, when it sank 98.8%.
- Scynexis' Other Non-Current Assets stood at $5.5 million in 2022, then slumped by 97.04% to $163000.0 in 2023, then soared by 155.83% to $417000.0 in 2024, then rose by 27.82% to $533000.0 in 2025, then slumped by 79.55% to $109000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $109000.0 (Q1 2026), $533000.0 (Q4 2025), and $417000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | 109,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109,000.00 |
| Dec 31, 2025 | 533,000.00 |
| Sep 30, 2025 | 417,000.00 |
| Jun 30, 2025 | 109,000.00 |
| Mar 31, 2025 | 417,000.00 |
| Dec 31, 2024 | 417,000.00 |
| Sep 30, 2024 | 109,000.00 |
| Jun 30, 2024 | 175,000.00 |
| Mar 31, 2024 | 163,000.00 |
| Dec 31, 2023 | 163,000.00 |
| Sep 30, 2023 | 164,000.00 |
| Jun 30, 2023 | 73,000.00 |
| Mar 31, 2023 | 163,000.00 |
| Dec 31, 2022 | 5.51 Mn |
| Sep 30, 2022 | 163,000.00 |
| Jun 30, 2022 | 6.08 Mn |
| Mar 31, 2022 | 124,000.00 |
| Dec 31, 2021 | 6.24 Mn |
| Sep 30, 2021 | 206,000.00 |
| Jun 30, 2021 | 1.41 Mn |